|
|
Volumn 14, Issue 2, 2002, Pages 166-174
|
|
The application of cost effectiveness analysis to derive a formulary for urinary tract infections
a
|
|
Author keywords
Antibiotic policy in hospital; Formulary pharmacoeconomics; Incremental analysis
|
|
Indexed keywords
AMIKACIN;
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
AMOXICILLIN PLUS CLAVULANIC ACID;
AMPICILLIN;
ANTIBIOTIC AGENT;
BETA LACTAM ANTIBIOTIC;
BETA LACTAMASE INHIBITOR;
CARBAPENEM DERIVATIVE;
CEFTAZIDIME;
CEPHALOSPORIN DERIVATIVE;
CIPROFLOXACIN;
COTRIMOXAZOLE;
IMIPENEM;
NALIDIXIC ACID;
NITROFURANTOIN;
NORFLOXACIN;
PEFLOXACIN;
PENICILLIN DERIVATIVE;
PIPERACILLIN;
PIPERACILLIN PLUS TAZOBACTAM;
QUINOLONE DERIVATIVE;
SULFONAMIDE;
TOBRAMYCIN;
UREIDOPENICILLIN DERIVATIVE;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
CONFERENCE PAPER;
COST EFFECTIVENESS ANALYSIS;
DRUG CHOICE;
DRUG EFFICACY;
DRUG FORMULARY;
ENTEROCOCCUS;
ESCHERICHIA COLI;
HUMAN;
ITALY;
KLEBSIELLA;
NONHUMAN;
POLICY;
PSEUDOMONAS AERUGINOSA;
URINARY TRACT INFECTION;
|
|
EID: 0036242524
PISSN: 1120009X
EISSN: None
Source Type: Journal
DOI: 10.1179/joc.2002.14.2.166 Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (19)
|
